Hainan Poly Pharm Co (SZSE:300630) Long-Term Debt : ¥1,900 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co Long-Term Debt?

Hainan Poly Pharm Co's Long-Term Debt for the quarter that ended in Sep. 2023 was ¥1,900 Mil.

Hainan Poly Pharm Co's quarterly Long-Term Debt increased from Mar. 2023 (¥1,805 Mil) to Jun. 2023 (¥2,147 Mil) but then declined from Jun. 2023 (¥2,147 Mil) to Sep. 2023 (¥1,900 Mil).

Hainan Poly Pharm Co's annual Long-Term Debt increased from Dec. 2020 (¥195 Mil) to Dec. 2021 (¥926 Mil) and increased from Dec. 2021 (¥926 Mil) to Dec. 2022 (¥1,481 Mil).

Hainan Poly Pharm Co Long-Term Debt Historical Data

The historical data trend for Hainan Poly Pharm Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co Long-Term Debt Chart

Hainan Poly Pharm Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Debt

Get a 7-Day Free Trial

49.45

194.81

925.85

1,481.05

Hainan Poly Pharm Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Long-Term Debt	Get a 7-Day Free Trial															1,418.04	1,481.05	1,805.21	2,147.01	1,900.06

Hainan Poly Pharm Co (SZSE:300630) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Hainan Poly Pharm Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Poly Pharm Co (SZSE:300630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051

Website

http://www.hnpoly.com

Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Executives

Fan De Zhu	Independent director
Xie Hui Fang	Supervisors
Pu Jian	Executives
Xu Zhao	Securities Affairs Representative
Shen Shi Hua	Executives
Zhou Mao	Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines